CVS Faces Major federal Lawsuit Over Opioid Prescriptions
Table of Contents
The Department of Justice (DOJ) filed a civil complaint Wednesday against CVS Pharmacy, alleging the nation’s largest pharmacy chain filled unlawful prescriptions, violating the federal Controlled Substances Act. The complaint also accuses CVS of seeking reimbursement from federal healthcare programs for these allegedly illegal prescriptions, a violation of the False Claims Act.With over 9,000 pharmacies nationwide, the implications of this lawsuit are far-reaching.
The DOJ alleges that from October 17, 2013, to the present, CVS dispensed dangerous and excessive quantities of opioids, filled prescriptions prematurely, and filled “trinity” prescriptions—a hazardous combination of opioids, benzodiazepines, and muscle relaxants. Furthermore, the complaint states that CVS knowingly filled large numbers of prescriptions written by doctors engaged in “pill mill practices,” prescribing controlled substances without legitimate medical reasons.
U.S. Attorney Zachary Cunha for the District of Rhode Island stated in a press release, “This lawsuit alleges that CVS failed to exercise its critical role as gatekeeper of dangerous prescription opioids and, rather, facilitated the illegal proliferation of these highly addictive drugs, including by pill mill prescribers.”
CVS vehemently denies the allegations. Amy Thibault, director of external communications for CVS, issued a written statement: “We will defend ourselves vigorously against this misguided federal lawsuit, wich follows on the heels of years of litigation over these issues by state and local governments—claims that already have been largely resolved by a global agreement with the participating state Attorneys General.” Thibault further emphasized that each prescription was for an FDA-approved medication prescribed by a licensed practitioner.
The potential penalties for CVS are substantial. If found liable, the company could face significant civil penalties for each unlawful prescription filled, plus treble damages and other penalties for prescriptions reimbursed by federal healthcare programs.
This lawsuit follows the recent $650 million settlement reached by McKinsey & Company for its role in boosting OxyContin sales. this is the latest in a series of actions by federal prosecutors to hold companies accountable for their contribution to the opioid crisis, which has claimed over 80,000 lives annually in recent years. While illicit fentanyl is now the leading cause of overdose deaths, prescription opioids played a significant role in the earlier stages of the epidemic.
over the past eight years,drug manufacturers,wholesalers,and pharmacies have collectively paid approximately $50 billion in settlements to various governments,with the majority of funds earmarked for combating the opioid crisis. This case underscores the ongoing efforts to address this devastating public health issue and hold accountable those deemed responsible for fueling the addiction epidemic.
Copyright 2024 The Associated Press. All rights reserved.
CVS Faces DOJ Lawsuit: Are Pharmacies Responsible for the Opioid Crisis?
The Department of Justice (DOJ) has filed a major lawsuit against CVS Pharmacy, alleging the company filled unlawful opioid prescriptions and sought reimbursement from federal healthcare programs for these prescriptions. This raises important questions about the role pharmacies play in the ongoing opioid epidemic.
To discuss the implications of this lawsuit,we spoke with Dr. Sarah Miller, a researcher specializing in public health policy and the opioid crisis.
The Allegations Against CVS
Senior Editor: Dr. Miller, can you break down the main allegations against CVS in this lawsuit?
Dr. Miller: The DOJ alleges that CVS engaged in several practices that contributed to the opioid crisis.They claim the company filled excessive opioid prescriptions, sometimes prematurely, and even filled “trinity” prescriptions which are dangerous combinations of opioids, benzodiazepines, and muscle relaxants. Furthermore, they allege CVS knowingly filled prescriptions from doctors operating “pill mills” – clinics that recklessly prescribe controlled substances.
CVS’ Response
Senior Editor: How has CVS responded to these allegations?
Dr. miller: CVS vehemently denies the allegations, stating they will “vigorously defend” themselves against the lawsuit. They argue that each prescription filled was for FDA-approved medications prescribed by licensed practitioners and emphasize that previous claims against them have largely been settled.
potential Impact and Future Implications
Senior Editor: What are the potential penalties for CVS if they are found liable?
Dr. Miller: The potential financial consequences for CVS are significant. They could face considerable civil penalties for each unlawful prescription filled, along with treble damages for prescriptions reimbursed by federal healthcare programs. This case could have far-reaching implications for the entire pharmacy industry, putting
pressure on all pharmacies to take more duty for the opioid crisis.
It’s critically important to remember that this lawsuit is part of a broader effort by federal prosecutors to hold companies accountable for their role in the opioid epidemic. We’ve already seen settlements from McKinsey & Company and other pharmaceutical companies. this case underscores the ongoing efforts to address this devastating public health problem.
